Silence Therapeutics (SLN) Current Leases (2019 - 2025)
Historic Current Leases for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $85000.0.
- Silence Therapeutics' Current Leases rose 14706.46% to $85000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $85000.0, marking a year-over-year increase of 14706.46%. This contributed to the annual value of $117000.0 for FY2024, which is 4868.42% down from last year.
- Per Silence Therapeutics' latest filing, its Current Leases stood at $85000.0 for Q3 2025, which was up 14706.46% from $60000.0 recorded in Q1 2025.
- In the past 5 years, Silence Therapeutics' Current Leases registered a high of $523126.0 during Q4 2022, and its lowest value of -$588095.6 during Q3 2022.
- In the last 5 years, Silence Therapeutics' Current Leases had a median value of -$180602.7 in 2024 and averaged -$110065.2.
- As far as peak fluctuations go, Silence Therapeutics' Current Leases plummeted by 124328.85% in 2021, and later soared by 18326.47% in 2022.
- Silence Therapeutics' Current Leases (Quarter) stood at $184677.4 in 2021, then skyrocketed by 183.26% to $523126.0 in 2022, then tumbled by 142.47% to -$222166.2 in 2023, then skyrocketed by 152.66% to $117000.0 in 2024, then fell by 27.35% to $85000.0 in 2025.
- Its Current Leases was $85000.0 in Q3 2025, compared to $60000.0 in Q1 2025 and $117000.0 in Q4 2024.